Mona Mohammad

Consultant Ocular Oncology

Education and Training

M.B.B.S in Medicine and Surgery, Jordan University of Science and Technology (JUST)
Higher Specialization in Ophthalmology, Faculty of medicine, University of Jordan, Jordan University Hospital
Clinical fellowship in Ocular Oncology, Periocular tumors and Oculoplasty, Moorfields Eye Hospital, London, UK
Residency in Higher Specialization in Ophthalmology, Faculty of medicine, University of Jordan, Jordan University Hospital

Board Certifications

Jordanian Board in Ophthalmology

Experience

2008-2012: Higher Specialization in Ophthalmology, Faculty of medicine, University of Jordan & Jordan University Hospital
2012-2016: Ophthalmology specialist, Private clinic
2016-2017: Ophthalmology specialist, Ocular oncology department, The King Hussein Cancer Center
2017-2019: Clinical fellowship in Ocular Oncology, Periocular tumors and Oculoplasty, Moorfields Eye Hospital, London, UK
2019-present: Consultant Ocular Oncologist, Ocular oncology department, King Hussein Cancer Canter

Professional Memberships

Jordan Medical Association
Jordanian Ophthalmic Society
Fellow of Royal College of Surgeon (FRCS) in Ophthalmology / Glasgow
Registered in General Medical Council of Britain with License to practice
Registered in Irish Medical Council

Publications

Primary apocrine adenocarcinoma of the orbit with lacrimal sac invasion. Mona Mohammad, Rashed M. Nazzal, Maysa AlHussaini, Niveen Abdullah Saleh, Sana' Muhsen, Robert Rejdak, Yacoub A. Yacoub. DOI: 10.5603/OJ.2020.0012·Ophthalmol J 2020;5:38-41
Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol. 2020 Feb 27;6(5):1-12. doi: 10.1001/jamaoncol.2019.6716. Online ahead of print.PMID: 32105305
Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.Yousef YA, Tbakhi A, Al-Hussaini M, AlNawaiseh I, Saab A, Afifi A, Naji M, Mohammad M, Deebajah R, Jaradat I, Sultan I, Mehyar M.Fam Cancer. 2018 Apr;17(2):261-268. doi: 10.1007/s10689-017-0027-5.PMID: 28803391
Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy. Yousef YA, Nazzal RM, Khalil MB, Deebajah R, Mehyar M, Hajja S, Mohammad M, Al Jabary R, Jaradat I, Sultan I, Al Nawaiseh I.Oman J Ophthalmol. 2017 May-Aug;10(2):70-75. doi: 10.4103/ojo.OJO_225_2015.PMID: 28757689
Characteristics, management, and outcome of squamous carcinoma of the conjunctiva in a single tertiary cancer center in Jordan. Rajeh A, Barakat F, Khurma S, AlRawashdeh K, Ababneh OH, AlNawaiseh I, Mehyar M, Abdeen G, Jaradat I, Mohammad M, Yousef YA.Int J Ophthalmol. 2018 Jul 18;11(7):1132-1138. doi: 10.18240/ijo.2018.07.10. eCollection 2018.PMID: 30046529
A rare case of extracranial meningioma in parapharyngeal space presented as a neck mass. Albsoul N, Rawashdeh B, Albsoul A, Abdullah M, Golestani S, Rawshdeh A, Mohammad M, Alzoubi M.Int J Surg Case Rep. 2015;11:40-43. doi: 10.1016/j.ijscr.2015.04.012. Epub 2015 Apr 13.PMID: 25912007
The predictive value of magnetic resonance imaging of retinoblastoma for the likelihood of high-risk pathologic features. Hiasat JG, Saleh A, Al-Hussaini M, Al Nawaiseh I, Mehyar M, Qandeel M, Mohammad M, Deebajah R, Sultan I, Jaradat I, Mansour A, Yousef YA.Eur J Ophthalmol. 2019 Mar;29(2):262-268. doi: 10.1177/1120672118781200. Epub 2018 Jun 11.PMID: 29890860
Concomitant Intraocular Retinoblastoma and Choroidal Hemangioma in a 1-Year-Old Boy. Yousef YA, Al-Hussaini M, Barakat FH, Saleh A, Mohammad M, Deebajah R.Turk Patoloji Derg. 2019;35(3):258-262. doi: 10.5146/tjpath.2017.01411.PMID: 28984344
Ocular manifestations of Behçet's disease in Jordanian patients. Abu-Ameerh MA, Mohammed SF, Mohammad MT, Ababneh OH, Al-Bdour MD.Saudi J Ophthalmol. 2013 Oct;27(4):247-51. doi: 10.1016/j.sjopt.2013.06.012. Epub 2013 Jul 1.PMID: 24371419
Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma. Yousef YA, Noureldin AM, Sultan I, Deebajah R, Al-Hussaini M, Shawagfeh M, Mehyar M, Mohammad M, Jaradat I, AlNawaiseh I.J Ophthalmol. 2020 Jan 24;2020:8628525. doi: 10.1155/2020/8628525. eCollection 2020.PMID: 32047663
The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy. Yousef YA, Mohammad M, Jaradat I, Shatnawi R, Banat S, Mehyar M, Al-Nawaiseh I.Ophthalmic Genet. 2020 Feb;41(1):20-25. doi: 10.1080/13816810.2020.1719519. Epub 2020 Feb 19.PMID: 3207284
Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children. Yousef YA, Alkhoms A, AlJabari R, AlJboor M, Mohammad M, Lahlouh M, Deebajah R, Halalsheh H, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, AlNawaiseh I.Ophthalmic Genet. 2020 May 20:1-7. doi: 10.1080/13816810.2020.1766085. Online ahead of print.PMID: 32432497
Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. Mehyar M, Mosallam M, Tbakhi A, Saab A, Sultan I, Deebajah R, Jaradat I, AlJabari R, Mohammad M, AlNawaiseh I, Al-Hussaini M, Yousef YA.Hematol Oncol Stem Cell Ther. 2020 Mar 23:S1658-3876(20)30039-X. doi: 10.1016/j.hemonc.2020.02.006. Online ahead of print.PMID: 32222358
Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease. Yousef YA, ElRimawi AH, Nazzal RM, Qaroot AF, AlAref AH, Mohammad M, Abureesh O, Rejdak R, Nowomiejska K, Avitabile T, Toro MD, AlNawaiseh I.Medicine (Baltimore). 2020 Apr;99(16):e19623. doi: 10.1097/MD.0000000000019623.PMID: 32311932

Academic Rank

Assistant Member

Contact Information

Email Address: dm.11804@khcc.jo
Phone Number: 0096265300460 - 7455